SHG — Singular Health Income Statement
0.000.00%
Last trade - 00:00- AU$16.25m
- AU$17.66m
- AU$1.03m
Annual income statement for Singular Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.128 | 0.461 | 0.425 | 1.03 |
| Cost of Revenue | ||||
| Gross Profit | — | — | — | 0.519 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.773 | 3.45 | 6.34 | 5.94 |
| Operating Profit | -0.645 | -2.99 | -5.91 | -4.9 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -0.708 | -4.46 | -5.99 | -5.39 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.708 | -4.46 | -5.99 | -5.39 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.708 | -4.46 | -5.99 | -5.39 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.708 | -4.46 | -5.99 | -5.39 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.015 | -0.062 | -0.058 | -0.048 |
| Dividends per Share |